WallStreetZenWallStreetZen

NYSE: EHC
Encompass Health Corp Stock Forecast, Predictions & Price Target

Open Broker Account
OverviewForecast
EarningsDividendOwnership

Analyst price target for EHC

Based on 10 analysts offering 12 month price targets for Encompass Health Corp.
Min Forecast
$62.00+34.4%
Avg Forecast
$70.50+52.83%
Max Forecast
$83.00+79.93%

Should I buy or sell EHC stock?

Based on 10 analysts offering ratings for Encompass Health Corp.
Strong Buy
Strong Buy
5 analysts 50%
Buy
5 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EHC stock forecasts and price targets.

EHC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Credit Suisse
Top 5%
96
BuyMaintains$62.00+34.40%2022-09-21
RBC Capital
Bottom 10%
10
BuyMaintains$66.00+43.07%2022-08-24
Truist Securities
Top 10%
91
Strong BuyMaintains$65.00+40.91%2022-08-08
BMO Capital
Top 10%
91
BuyMaintains$65.00+40.91%2022-08-04
Raymond James
Bottom 15%
15
Strong BuyMaintains$65.00+40.91%2022-08-04
Barclays
Bottom 18%
18
Strong BuyMaintains$63.00+36.57%2022-08-04
Stephens & Co.
Top 8%
93
Strong BuyMaintains$74.00+60.42%2022-06-21
Credit Suisse
Top 25%
76
BuyMaintains$82.00+77.76%2022-06-10
Credit Suisse
Bottom 16%
16
BuyMaintains$83.00+79.93%2022-04-29
Mizuho
Bottom 34%
34
Strong BuyMaintains$80.00+73.42%2021-11-03

1 of 1

Forecast return on equity

Is EHC forecast to generate an efficient return?
Company
17.43%
Industry
-35.43%
Market
108.8%
EHC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is EHC forecast to generate an efficient return on assets?
Company
4.93%
Industry
7.32%
EHC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EHC earnings per share forecast

What is EHC's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$2.67-19.34%
Avg 2 year Forecast
$3.33+0.6%
Avg 3 year Forecast
$3.50+5.74%
EHC's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

EHC revenue forecast

What is EHC's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$4.3B-18.73%
Avg 2 year Forecast
$4.6B-12.86%
Avg 3 year Forecast
$5.0B-4.44%
EHC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EHC earnings growth forecast

How is EHC forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
-0.81%
Industry
2.4%
Market
18.65%
EHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
EHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
EHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

EHC revenue growth forecast

How is EHC forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
-6.38%
Industry
6.77%
Market
8.28%
EHC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EHC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EHC vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
EHC$46.13$70.50+52.83%Strong Buy
AMN$101.65$136.60+34.38%Strong Buy
ENSG$79.55$95.25+19.74%Buy
CANO$8.69$10.44+20.18%Buy
LHCG$164.31$170.38+3.69%Hold
View Top Medical Care Facility Stocks

Encompass Health Stock Forecast FAQ

Is Encompass Health Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NYSE: EHC) stock is to Strong Buy EHC stock.

Out of 10 analysts, 5 (50%) are recommending EHC as a Strong Buy, 5 (50%) are recommending EHC as a Buy, 0 (0%) are recommending EHC as a Hold, 0 (0%) are recommending EHC as a Sell, and 0 (0%) are recommending EHC as a Strong Sell.

If you're new to stock investing, here's how to buy Encompass Health stock.

What is EHC's earnings growth forecast for 2022-2024?

(NYSE: EHC) Encompass Health's forecast annual earnings growth rate of -0.81% is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 2.4%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.65%.

Encompass Health's earnings in 2022 is $423,800,000.On average, 3 Wall Street analysts forecast EHC's earnings for 2022 to be $266,406,261, with the lowest EHC earnings forecast at $224,499,659, and the highest EHC earnings forecast at $287,359,563. On average, 7 Wall Street analysts forecast EHC's earnings for 2023 to be $332,259,495, with the lowest EHC earnings forecast at $268,401,814, and the highest EHC earnings forecast at $429,043,792.

In 2024, EHC is forecast to generate $349,221,691 in earnings, with the lowest earnings forecast at $349,221,691 and the highest earnings forecast at $349,221,691.

What is EHC's revenue growth forecast for 2022-2024?

(NYSE: EHC) Encompass Health's forecast annual revenue growth rate of -6.38% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.28%.

Encompass Health's revenue in 2022 is $5,267,600,000.On average, 4 Wall Street analysts forecast EHC's revenue for 2022 to be $427,164,979,102, with the lowest EHC revenue forecast at $425,769,090,115, and the highest EHC revenue forecast at $428,245,570,792. On average, 5 Wall Street analysts forecast EHC's revenue for 2023 to be $458,021,209,943, with the lowest EHC revenue forecast at $447,368,950,591, and the highest EHC revenue forecast at $467,118,933,882.

In 2024, EHC is forecast to generate $502,250,635,996 in revenue, with the lowest revenue forecast at $502,250,635,996 and the highest revenue forecast at $502,250,635,996.

What is EHC's forecast return on assets (ROA) for 2022-2024?

(NYSE: EHC) forecast ROA is 4.93%, which is lower than the forecast US Medical Care Facilities industry average of 7.32%.

What is EHC's Price Target?

According to 10 Wall Street analysts that have issued a 1 year EHC price target, the average EHC price target is $70.50, with the highest EHC stock price forecast at $83.00 and the lowest EHC stock price forecast at $62.00.

On average, Wall Street analysts predict that Encompass Health's share price could reach $70.50 by Sep 21, 2023. The average Encompass Health stock price prediction forecasts a potential upside of 52.83% from the current EHC share price of $46.13.

What is EHC's Earnings Per Share (EPS) forecast for 2022-2024?

(NYSE: EHC) Encompass Health's current Earnings Per Share (EPS) is $3.31. On average, analysts forecast that EHC's EPS will be $2.67 for 2022, with the lowest EPS forecast at $2.25, and the highest EPS forecast at $2.88. On average, analysts forecast that EHC's EPS will be $3.33 for 2023, with the lowest EPS forecast at $2.69, and the highest EPS forecast at $4.30. In 2024, EHC's EPS is forecast to hit $3.50 (min: $3.50, max: $3.50).

What is EHC's forecast return on equity (ROE) for 2022-2024?

(NYSE: EHC) forecast ROE is 17.43%, which is considered weak.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market Industries
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.